Corrigendum to “Oral olsalazine/ellagic acid/ZnCl2-modified in situ-forming hydrogels alleviates anxiety/depression-like symptoms and brain neural activity in colitis mice” [Mater Today Bio. 2025 Jul 8; 33:102058]
Authors
- Wenqiang Chen (ORCID: https://orcid.org/0000-0002-5532-9319)
- Dexiang Liu (ORCID: https://orcid.org/0000-0001-5023-4874)
- Haoyu Sheng
- Ningting Li
- Su Liu
- Tingting Li (ORCID: https://orcid.org/0000-0002-8644-1338)
- Zhen Wang (ORCID: https://orcid.org/0000-0003-3173-6961)
- Qian Luo (ORCID: https://orcid.org/0000-0002-1819-6043)
- Luyao Zhang (ORCID: https://orcid.org/0000-0002-9522-4554)
- Yijing Zhao (ORCID: https://orcid.org/0009-0009-7531-1528)
Institutions
- Shandong University (CN)
- Shandong Provincial QianFoShan Hospital (CN)
- Qilu Hospital of Shandong University (CN)